510(k) Report

510(k) · Cleared

Recalled · 2010

Hemochron (R) Heparin Response Test

K904003510(k) TraditionalCleared Nov 29, 199092-day reviewClass II21 CFR 864.7525Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Intensive Technology, Inc. · KFF Assay, Heparin

Cleared on Nov 29, 1990 after a 92-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled once.

Decided
Nov 29, 1990
Review
92 days
Class
Class II
Product code
KFF
Recalls
1
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K904003Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KFF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KFF device

  1. #1 K260214 STA® - Liquid Anti-Xascore 12.4 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 24, 2010Not classifiedZ-2110-2010OtherAn ingredient in the RQCHRT Whole Blood Controls for use with Hemochron Kaolin and Celite HRT Test tubes may become less potent over time and result in excessive High LQC Failures.

No ancestor or descendant has a Class I recall.

How does its category compare?

All KFF devices

KFF Assay, Heparin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KFF

1in 2022

2009: 12011: 12017: 12022: 12026 (partial year): 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KFF

Too few KFF 510(k)s in any year since 2007 to give a median.

Recalls per year · KFF

1in 2024

2010: 12021: 12024: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KFF

7in 2025

2007: 12013: 42014: 32017: 42018: 52019: 12021: 42022: 12025: 7
2007high 7 (2025) · low 0 (2008)2025

MAUDE reports naming product code KFF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—01
20080—00
20091—00
20100—10
20111—00
20120—00
20130—04
20140—03
20150—00
20160—00
20171—04
20180—05
20190—01
20200—00
20210—14
20221—01
20230—00
20240—10
20250—07
20261—0—
Cite this page

510(k) Report. “K904003: Hemochron (R) Heparin Response Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K904003

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026